hims novo nordisk - Search News

Hims & Hers shares surge

Hims & Hers shares surge after Novo Nordisk drops patent infringement case over compounded weight loss drugs

Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.

· 1d

Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration

· 1d · on MSN

Novo Nordisk to sell weight-loss drugs through Hims & Hers

1don MSN

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

By Stine Jacobsen and Maggie Fick COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' platform, the ...

1don MSN

Hims & Hers Shares Double on Report of Wegovy Tie-Up

Stock skyrocketed premarket following a media report that the maker of Wegovy plans to sell the weight-loss drug on the Hims ...

Novo Nordisk Targets Obesity Edges With Irish Spend And Hims Alliance

Novo Nordisk (CPSE:NOVO B) is committing €432 million to expand its oral GLP-1 manufacturing facility in Ireland, aimed at supporting future products and supply outside the US. The company has settled ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results